The genetically engineered APPSwe/PS1dE9 mice, that concurrently express mutations in the human APP and PS1 genes, serve as an AD animal model, being characterized by a succession of distinct symptoms of AD patients. The gene discussed is APP; the disease is Alzheimer disease.